Back to User profile » Dr Donald Nixon
Papers published by Dr Donald Nixon:
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Early Canadian Real-World Experience with Brolucizumab in Anti-Vascular Endothelial Growth Factor-Experienced Patients with Neovascular Age-Related Macular Degeneration: A Retrospective Chart Review
Giunta M, Gauvin Meunier LP, Nixon D, Steeves J, Noble J
Clinical Ophthalmology 2022, 16:2885-2894
Published Date: 30 August 2022
Contrast Sensitivity Changes in Center Involving Diabetic Macular Edema Treated with Aflibercept
Nixon DR, Flinn N, Enderlein C
Clinical Ophthalmology 2021, 15:4439-4445
Published Date: 11 November 2021
Visual Function for Driving in Diabetic Macular Edema and Retinal Vein Occlusion Post-Stabilization with Anti-Vascular Endothelial Growth Factor
Nixon DR, Flinn N
Clinical Ophthalmology 2021, 15:1659-1666
Published Date: 20 April 2021
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Evaluation of contrast sensitivity and other visual function outcomes in diabetic macular edema patients following treatment switch to aflibercept from ranibizumab
Nixon DR, Flinn NAP
Clinical Ophthalmology 2018, 12:191-197
Published Date: 22 January 2018
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Evaluation of contrast sensitivity and other visual function outcomes in neovascular age-related macular degeneration patients after treatment switch to aflibercept from ranibizumab
Nixon DR, Flinn NAP
Clinical Ophthalmology 2017, 11:715-721
Published Date: 18 April 2017
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
An observational study of bimatoprost 0.01% in patients on prior intraocular pressure-lowering therapy: the Canadian Lumigan® RC Early Analysis Review (CLEAR) trial
Crichton AC, Nixon DR, Simonyi S, Bhogal M, Sigouin CS, Discepola MJ, Hutnik CML, Baptiste DC, Yan DB
Clinical Ophthalmology 2014, 8:1031-1038
Published Date: 23 May 2014
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
An observational study of bimatoprost 0.01% in treatment-naïve patients with primary open angle glaucoma or ocular hypertension: the CLEAR trial
Nixon DR, Simonyi S, Bhogal M, Sigouin CS, Crichton AC, Discepola M, Hutnik CML, Yan DB
Clinical Ophthalmology 2012, 6:2097-2103
Published Date: 18 December 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Twelve-week, randomized, multicenter study comparing a fixed combination of brimonidine-timolol with timolol as therapy adjunctive to latanoprost
Fechtner RD, Harasymowycz P, Nixon DR, Vold SD, Zaman F, Williams JM, Hollander DA
Clinical Ophthalmology 2011, 5:945-953
Published Date: 8 July 2011